NTRA - Natera expects Q2 revenue $138M-$141M consensus $127.48M

Natera's (NTRA) revenue and volume growth rate in Q2 2021 was the largest Y/Y growth in its history as a publicly traded company.Total revenues for the Q2 of 2021 are expected to be ~$138-$141M vs. consensus of $127.48M, which represents ~60% Y/Y growth.The Co. expects its product revenues to be ~$135-$137M, representing ~70% Y/Y growth.During Q2 2021, the Co. processed ~0.37M tests, which represents ~58% Y/Y growth. Also expects, its Women's Health business will be its first business unit to achieve cash flow breakeven operations, which represents a major milestone for the Co. The Co. will recognize a loss from operations of ~$113-$117M for Q2, reflecting increase in R&D and S, G&A costs in support of the commercialization of its new product offerings, which are expected to continue in subsequent quarters.

For further details see:

Natera expects Q2 revenue $138M-$141M, consensus $127.48M